Clinical Trials Browser

NCT01087294 2026-03-11

Administration of Anti-CD19-chimeric-antigen-receptor-transduced T Cells From the Original Transplant Donor to Patients With Recurrent or Persistent B-cell Malignancies After Allogeneic Stem Cell Transplantation

Phase 1 Completed

85 enrolled

LymphoidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell

NCT01803152 2024-07-03

Dendritic Cell Vaccine for Children and Adults With Sarcoma

Phase 1 Completed

19 enrolled

Sarcoma

Bone Neoplasms, Sarcoma

NCT00968760 2023-12-19

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

Phase 1 Completed

34 enrolled

LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT02728531 2023-11-01

Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma

Phase 1 Completed

18 enrolled

Lymphoid

Lymphoma, Mantle-Cell

NCT03338972 2023-09-08

Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma

Phase 1 Completed

28 enrolled 18 charts

Plasma cell

Multiple Myeloma

NCT02431988 2023-04-28

COBALT

Phase 1 Completed

10 enrolled

Lymphoid

Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03532217 2022-08-05

Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer

Phase 1 Completed

19 enrolled

Genitourinary

Metastatic Hormone-Sensitive Prostate Cancer

NCT01808820 2022-07-20

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Phase 1 Completed

20 enrolled

CNS

Astrocytoma, Glioblastoma, Glioma

NCT02761915 2021-08-17

A Phase I Trial of Anti-GD2 T-cells (1RG-CART)

Phase 1 Completed

17 enrolled 17 charts

CNS

Cytokine Release Syndrome, Neuroblastoma, Recurrence

NCT00005617 2020-08-03

Vaccine Therapy in Treating Patients With Stage IV or Relapsed Malignant Melanoma

Phase 1 Completed

Dermatologic

Melanoma

NCT01653717 2017-08-17

CD19-specific T-cell for Chronic Lymphocytic Leukemia (CLL)

Phase 1 Completed

30 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00089453 2012-04-19

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

Phase 1 Completed

10 enrolled

Plasma cell

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell